Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q9XZY9
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006631 | fatty acid metabolic process | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0016491 | oxidoreductase activity | 2 | 4 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 2 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4 | 2 |
GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity | 5 | 2 |
GO:0003960 | NADPH:quinone reductase activity | 5 | 2 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 3 | 2 |
GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 279 | 283 | PF00656 | 0.512 |
CLV_NRD_NRD_1 | 231 | 233 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 300 | 302 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.368 |
CLV_NRD_NRD_1 | 367 | 369 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 433 | 435 | PF00675 | 0.597 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 300 | 302 | PF00082 | 0.383 |
CLV_PCSK_KEX2_1 | 367 | 369 | PF00082 | 0.513 |
CLV_PCSK_KEX2_1 | 433 | 435 | PF00082 | 0.578 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 189 | 193 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 231 | 235 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 291 | 295 | PF00082 | 0.338 |
CLV_PCSK_SKI1_1 | 354 | 358 | PF00082 | 0.325 |
CLV_PCSK_SKI1_1 | 428 | 432 | PF00082 | 0.576 |
DEG_APCC_DBOX_1 | 230 | 238 | PF00400 | 0.372 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.598 |
DOC_CKS1_1 | 405 | 410 | PF01111 | 0.544 |
DOC_CYCLIN_RxL_1 | 226 | 236 | PF00134 | 0.394 |
DOC_CYCLIN_RxL_1 | 238 | 247 | PF00134 | 0.369 |
DOC_MAPK_gen_1 | 189 | 199 | PF00069 | 0.360 |
DOC_MAPK_gen_1 | 300 | 310 | PF00069 | 0.409 |
DOC_MAPK_gen_1 | 353 | 359 | PF00069 | 0.356 |
DOC_MAPK_MEF2A_6 | 44 | 53 | PF00069 | 0.310 |
DOC_PP1_RVXF_1 | 284 | 291 | PF00149 | 0.302 |
DOC_PP1_RVXF_1 | 426 | 433 | PF00149 | 0.570 |
DOC_PP2B_LxvP_1 | 54 | 57 | PF13499 | 0.291 |
DOC_PP4_FxxP_1 | 293 | 296 | PF00568 | 0.328 |
DOC_PP4_FxxP_1 | 432 | 435 | PF00568 | 0.625 |
DOC_USP7_MATH_1 | 174 | 178 | PF00917 | 0.344 |
DOC_USP7_MATH_1 | 349 | 353 | PF00917 | 0.410 |
DOC_USP7_MATH_1 | 419 | 423 | PF00917 | 0.612 |
DOC_USP7_UBL2_3 | 100 | 104 | PF12436 | 0.361 |
DOC_WW_Pin1_4 | 404 | 409 | PF00397 | 0.549 |
LIG_14-3-3_CanoR_1 | 231 | 240 | PF00244 | 0.377 |
LIG_14-3-3_CanoR_1 | 367 | 376 | PF00244 | 0.522 |
LIG_Actin_WH2_2 | 88 | 106 | PF00022 | 0.367 |
LIG_ActinCP_TwfCPI_2 | 432 | 439 | PF01115 | 0.605 |
LIG_CaM_IQ_9 | 179 | 194 | PF13499 | 0.326 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.323 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.383 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.352 |
LIG_FHA_2 | 405 | 411 | PF00498 | 0.650 |
LIG_LIR_Apic_2 | 343 | 349 | PF02991 | 0.407 |
LIG_LIR_Apic_2 | 36 | 41 | PF02991 | 0.395 |
LIG_LIR_Apic_2 | 365 | 369 | PF02991 | 0.505 |
LIG_LIR_Apic_2 | 402 | 408 | PF02991 | 0.545 |
LIG_LIR_Apic_2 | 429 | 435 | PF02991 | 0.617 |
LIG_LIR_Gen_1 | 157 | 168 | PF02991 | 0.341 |
LIG_LIR_Gen_1 | 407 | 417 | PF02991 | 0.541 |
LIG_LIR_Nem_3 | 157 | 163 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 407 | 412 | PF02991 | 0.557 |
LIG_NRBOX | 254 | 260 | PF00104 | 0.349 |
LIG_OCRL_FandH_1 | 408 | 420 | PF00620 | 0.647 |
LIG_Pex14_2 | 290 | 294 | PF04695 | 0.335 |
LIG_Pex14_2 | 342 | 346 | PF04695 | 0.374 |
LIG_REV1ctd_RIR_1 | 208 | 218 | PF16727 | 0.424 |
LIG_REV1ctd_RIR_1 | 429 | 434 | PF16727 | 0.595 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 251 | 255 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 143 | 146 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 406 | 409 | PF00017 | 0.549 |
LIG_SH3_3 | 234 | 240 | PF00018 | 0.362 |
LIG_SH3_3 | 432 | 438 | PF00018 | 0.585 |
LIG_SUMO_SIM_anti_2 | 128 | 134 | PF11976 | 0.368 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.509 |
MOD_CK1_1 | 393 | 399 | PF00069 | 0.542 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.395 |
MOD_GlcNHglycan | 337 | 340 | PF01048 | 0.528 |
MOD_GlcNHglycan | 392 | 395 | PF01048 | 0.531 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.375 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.321 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.434 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.295 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.335 |
MOD_GSK3_1 | 264 | 271 | PF00069 | 0.343 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.399 |
MOD_GSK3_1 | 390 | 397 | PF00069 | 0.537 |
MOD_N-GLC_1 | 244 | 249 | PF02516 | 0.329 |
MOD_N-GLC_1 | 269 | 274 | PF02516 | 0.495 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.572 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.302 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.346 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.331 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.529 |
MOD_NEK2_1 | 318 | 323 | PF00069 | 0.442 |
MOD_NEK2_1 | 340 | 345 | PF00069 | 0.382 |
MOD_NEK2_1 | 390 | 395 | PF00069 | 0.529 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.411 |
MOD_NEK2_2 | 145 | 150 | PF00069 | 0.311 |
MOD_PIKK_1 | 318 | 324 | PF00454 | 0.437 |
MOD_PKA_1 | 300 | 306 | PF00069 | 0.358 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.572 |
MOD_PKA_2 | 300 | 306 | PF00069 | 0.409 |
MOD_PKA_2 | 43 | 49 | PF00069 | 0.433 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.295 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.412 |
MOD_Plk_4 | 412 | 418 | PF00069 | 0.618 |
MOD_ProDKin_1 | 404 | 410 | PF00069 | 0.548 |
MOD_SUMO_rev_2 | 414 | 422 | PF00179 | 0.533 |
TRG_DiLeu_BaEn_1 | 203 | 208 | PF01217 | 0.404 |
TRG_DiLeu_BaLyEn_6 | 229 | 234 | PF01217 | 0.375 |
TRG_ENDOCYTIC_2 | 406 | 409 | PF00928 | 0.555 |
TRG_ER_diArg_1 | 230 | 232 | PF00400 | 0.381 |
TRG_ER_diArg_1 | 299 | 301 | PF00400 | 0.375 |
TRG_ER_diArg_1 | 307 | 310 | PF00400 | 0.394 |
TRG_ER_diArg_1 | 366 | 368 | PF00400 | 0.507 |
TRG_ER_diArg_1 | 432 | 434 | PF00400 | 0.609 |
TRG_Pf-PMV_PEXEL_1 | 231 | 236 | PF00026 | 0.387 |
TRG_Pf-PMV_PEXEL_1 | 63 | 67 | PF00026 | 0.410 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2X4 | Leptomonas seymouri | 92% | 100% |
A0A0S4ILA6 | Bodo saltans | 27% | 100% |
A0A0S4J2L6 | Bodo saltans | 72% | 100% |
A0A1X0NL46 | Trypanosomatidae | 82% | 97% |
A0A3R7KI38 | Trypanosoma rangeli | 81% | 100% |
A0A3S5H593 | Leishmania donovani | 100% | 100% |
A0A3S5H5I3 | Leishmania donovani | 30% | 100% |
A4H3U9 | Leishmania braziliensis | 96% | 100% |
A4H498 | Leishmania braziliensis | 29% | 100% |
A4HS24 | Leishmania infantum | 99% | 100% |
A4HSH5 | Leishmania infantum | 30% | 100% |
C9ZY17 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 82% | 100% |
E9AK11 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 99% |
E9AKF8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
Q10488 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 100% |
Q28GQ2 | Xenopus tropicalis | 28% | 100% |
Q4QJF0 | Leishmania major | 30% | 100% |
Q54YT4 | Dictyostelium discoideum | 33% | 100% |
Q6BLV6 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 27% | 100% |
Q6BV30 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 23% | 100% |
Q6CBE4 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 25% | 100% |
Q6CIR6 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 26% | 100% |
Q8LCU7 | Arabidopsis thaliana | 31% | 100% |
Q8NJJ9 | Kluyveromyces marxianus | 25% | 100% |
Q8WZM3 | Candida tropicalis | 25% | 100% |
Q8WZM4 | Candida tropicalis | 25% | 100% |
Q9V6U9 | Drosophila melanogaster | 29% | 100% |
V5D9R3 | Trypanosoma cruzi | 83% | 98% |